Patient Recruitment and Data Analysis

患者招募和数据分析

基本信息

  • 批准号:
    8196615
  • 负责人:
  • 金额:
    $ 57.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-25 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

The Patient Recruitment and Data Analysis Core (PRDAC) is an assembly of experienced investigators, staff, and material resources that will provide vital infrastructure support to this Asthma and Allergic Diseases Cooperative Research Center (AADCRC) application. The PRDAC is headed by Dr. Jerry A. Krishnan, MD, PhD, Associate Professor of Medicine and Epidemiology, Director of the Department of Medicine Data Management and Statistics Core, and a board-certified pulmonary physician with expertise in clinical investigation in asthma. Dr. Dan Nicolae, PhD, Associate Professor of Human Genetics and Statistics, will be the lead statistician in the PRDAC and will serve as core co-Leader. The PRDAC will be responsible for managing the recruitment of participants for the clinical studies as well as the performance of high quality data management and statistical analysis functions for this AADCRC application. Participant recruitment is one of the most demanding aspects of clinical studies and the expertise and resources it requires are frequently underestimated. We are currently recruiting subjects for multiple NIH-funded studies in airway disease and this work has allowed us to develop the appropriate expertise and an understanding of the resources needed to successfully screen, approach, and enroll study subjects, to collect clinical, physiologic, and biological data (including airway specimens from bronchoscopy) using research protocols, and to perform high-quality data management/statistical analysis. We have taken advantage of this collective experience in designing the proposed PRDAC and PRDAC budget. The three projects will recruit from a common pool of patients with asthma. Therefore, we elected to coordinate our recruitment efforts through the PRDAC to: 1) eliminate the need to duplicate or to compete for recruitment-related resources, thereby improving the efficiency with which our investigators meet enrollment targets, and 2) ensure that a uniform baseline characterization of asthma is employed across projects, permitting the opportunity for cross-study syntheses of findings. The PRDAC will be responsible for coordinating and developing reports for patient recruitment and human subjects research activities for our Data Safety and Monitoring Plan for review by the University of Chicago IRB and by the NIAID Project officer. In addition, the PRDAC will collaborate with project leaders and co-investigators within other projects/cores to ensure a timely transmission of findings via reports, abstracts, and manuscripts. The PRDAC, therefore, will facilitate the efficient and successful completion of studies proposed in each project and promote the synthesis and dissemination of knowledge gained across the various studies.
患者招募和数据分析核心(PRDAC)是经验丰富的研究人员的集合, 工作人员和物质资源,将提供重要的基础设施支持,这哮喘和过敏性疾病合作研究中心(AADCRC)的申请。PRDAC由Jerry A博士领导。克里希南 医学博士,医学和流行病学副教授,医学系主任 数据管理和统计核心,以及具有临床专业知识的委员会认证的肺科医生 哮喘的调查。丹尼古拉博士,博士,人类遗传学和统计学副教授,将 担任PRDAC的首席统计师,并将担任核心共同负责人。PRDAC将负责 管理临床研究参与者的招募以及高质量数据的表现 该AADCRC应用程序的管理和统计分析功能。参与者招募是一个 临床研究最苛刻的方面,以及它所需要的专业知识和资源, 低估我们目前正在为多项NIH资助的气道疾病研究招募受试者, 这项工作使我们能够发展适当的专业知识,并了解所需的资源 成功筛选、接近和入组研究受试者,收集临床、生理和生物学数据 (包括支气管镜检查的气道标本)使用研究协议,并执行高质量的数据 管理/统计分析。我们利用这一集体经验, PRDAC和PRDAC预算。这三个项目将从一个共同的患者库中招募, 哮喘因此,我们选择通过PRDAC协调我们的招聘工作,以:1)消除 需要重复或竞争与征聘有关的资源,从而提高 我们的研究者达到了招募目标,2)确保哮喘的基线特征是一致的, 跨项目使用,允许交叉研究综合结果的机会。PRDAC将 负责协调和编写患者招募和人体受试者研究报告 由芝加哥大学IRB和 NIAID项目官员。此外,PRDAC将与项目负责人和共同研究者合作, 其他项目/核心,以确保通过报告、摘要和手稿及时传递调查结果。的 因此,PRDAC将促进高效、成功地完成每个项目中提出的研究 并促进综合和传播从各种研究中获得的知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jerry A. Krishnan其他文献

Signal processing through a generalized module of adaptation and spatial sensing.
通过适应和空间感知的通用模块进行信号处理。
  • DOI:
    10.1016/j.jtbi.2009.02.015
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Jerry A. Krishnan
  • 通讯作者:
    Jerry A. Krishnan
A Practical Guide to Implementing SMART in Asthma Management
  • DOI:
    10.1016/j.jaip.2021.10.011
  • 发表时间:
    2022-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Helen K. Reddel;Eric D. Bateman;Michael Schatz;Jerry A. Krishnan;Michelle M. Cloutier
  • 通讯作者:
    Michelle M. Cloutier
Erratum to: Misuse of Respiratory Inhalers in Hospitalized Patients with Asthma or COPD
  • DOI:
    10.1007/s11606-011-1671-3
  • 发表时间:
    2011-02-25
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Valerie G. Press;Vineet M. Arora;Lisa M. Shah;Stephanie L. Lewis;Krystal Ivy;Jeffery Charbeneau;Sameer Badlani;Edward Nareckas;Antoinette Mazurek;Jerry A. Krishnan
  • 通讯作者:
    Jerry A. Krishnan
A modelling framework describing the enzyme regulation of membrane lipids underlying gradient perception in Dictyostelium cells II: input-output analysis.
描述盘基网柄菌细胞 II 中梯度感知的膜脂酶调节的建模框架:输入输出分析。
  • DOI:
    10.1016/j.jtbi.2005.02.004
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Jerry A. Krishnan;Pablo A. Iglesias
  • 通讯作者:
    Pablo A. Iglesias
Irregular assessment times in pragmatic randomized clinical trials
  • DOI:
    10.1186/s13063-024-08676-8
  • 发表时间:
    2024-12-20
  • 期刊:
  • 影响因子:
    2.000
  • 作者:
    Andrea Apter;Frances K. Barg;Sanjib Basu;Alex Federman;Winifred J. Hamilton;Jerry A. Krishnan;Tianjing Li;Russell Localio;Christine Pindle;Daniel O. Scharfstein;Justin D. Smith;Kaharu Sumino
  • 通讯作者:
    Kaharu Sumino

Jerry A. Krishnan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jerry A. Krishnan', 18)}}的其他基金

Patient Recruitment and Data Analysis
患者招募和数据分析
  • 批准号:
    8380129
  • 财政年份:
    2012
  • 资助金额:
    $ 57.14万
  • 项目类别:
Chicagoland Metropolitan AsthmaNet Consortium (CMAC)
芝加哥大都会哮喘网络联盟 (CMAC)
  • 批准号:
    8882517
  • 财政年份:
    2009
  • 资助金额:
    $ 57.14万
  • 项目类别:
Chicagoland Metropolitan AsthmaNet Consortium (CMAC)
芝加哥大都会哮喘网络联盟 (CMAC)
  • 批准号:
    8495398
  • 财政年份:
    2009
  • 资助金额:
    $ 57.14万
  • 项目类别:
Chicagoland Metropolitan AsthmaNet Consortium (CMAC)
芝加哥大都会哮喘网络联盟 (CMAC)
  • 批准号:
    8691990
  • 财政年份:
    2009
  • 资助金额:
    $ 57.14万
  • 项目类别:
Chicagoland Metropolitan AsthmaNet Consortium (CMAC)
芝加哥大都会哮喘网络联盟 (CMAC)
  • 批准号:
    8299068
  • 财政年份:
    2009
  • 资助金额:
    $ 57.14万
  • 项目类别:
Setting effectiveness and translational research priorities to improve COPD care
设定有效性和转化研究重点以改善慢性阻塞性肺病护理
  • 批准号:
    7614932
  • 财政年份:
    2008
  • 资助金额:
    $ 57.14万
  • 项目类别:
Setting effectiveness and translational research priorities to improve COPD care
设定有效性和转化研究重点以改善慢性阻塞性肺病护理
  • 批准号:
    7679021
  • 财政年份:
    2008
  • 资助金额:
    $ 57.14万
  • 项目类别:
PATIENT RECRUITMENT/DATA MANAGEMENT CORE
患者招募/数据管理核心
  • 批准号:
    7499337
  • 财政年份:
    2007
  • 资助金额:
    $ 57.14万
  • 项目类别:
MACROLIDES TO PREVENT EXACERBATIONS OF ASTHMA
大环内酯类药物预防哮喘恶化
  • 批准号:
    7604653
  • 财政年份:
    2006
  • 资助金额:
    $ 57.14万
  • 项目类别:
Increasing adherence in inner-city adults with asthma
提高市中心成人哮喘患者的依从性
  • 批准号:
    6361153
  • 财政年份:
    2001
  • 资助金额:
    $ 57.14万
  • 项目类别:

相似海外基金

Testing the effectiveness of the biological drug, Tezepelumab, in patients with coexisting allergic rhinitis and allergic asthma
测试生物药物 Tezepelumab 对同时患有过敏性鼻炎和过敏性哮喘的患者的有效性
  • 批准号:
    490921
  • 财政年份:
    2022
  • 资助金额:
    $ 57.14万
  • 项目类别:
    Studentship Programs
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
  • 批准号:
    10396626
  • 财政年份:
    2021
  • 资助金额:
    $ 57.14万
  • 项目类别:
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
  • 批准号:
    10216007
  • 财政年份:
    2021
  • 资助金额:
    $ 57.14万
  • 项目类别:
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
  • 批准号:
    10615633
  • 财政年份:
    2021
  • 资助金额:
    $ 57.14万
  • 项目类别:
Sex as a biological variable: Immunomodulatory mechanisms of Innate Defence Regulator (IDR) peptides in asthma
性别作为生物变量:先天防御调节剂 (IDR) 肽在哮喘中的免疫调节机制
  • 批准号:
    449782
  • 财政年份:
    2020
  • 资助金额:
    $ 57.14万
  • 项目类别:
    Studentship Programs
Potential biological mechanisms with regard to the association betwen asthma and obesity
哮喘与肥胖之间关联的潜在生物学机制
  • 批准号:
    17K09599
  • 财政年份:
    2017
  • 资助金额:
    $ 57.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
  • 批准号:
    7434307
  • 财政年份:
    2008
  • 资助金额:
    $ 57.14万
  • 项目类别:
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
  • 批准号:
    8092713
  • 财政年份:
    2008
  • 资助金额:
    $ 57.14万
  • 项目类别:
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
  • 批准号:
    7685408
  • 财政年份:
    2008
  • 资助金额:
    $ 57.14万
  • 项目类别:
Phenotypic and biological features of mucus plugs in asthma
哮喘粘液栓的表型和生物学特征
  • 批准号:
    10654049
  • 财政年份:
    2005
  • 资助金额:
    $ 57.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了